Login / Signup

An evidence-based, risk-adapted algorithm for antifungal prophylaxis reduces risk for invasive mold infections in children with hematologic malignancies.

Ankhi DuttaAshley IkwuezunmaMaria I CastellanosJulienne BrackettKiranmye ReddyPriya MahajanAnn M MarshburnKala Y KamdarHana PaekDebra L PalazziKaren R RabinMichael E ScheurerMaria Monica J Gramatges
Published in: Pediatric blood & cancer (2021)
An evidence-based, risk-adapted approach to antifungal prophylaxis for children with hematologic malignancies is an effective strategy to reduce incidence of IMI.
Keyphrases
  • young adults
  • machine learning
  • risk factors